Secretory Group II Phospholipase A 2
- 31 March 2000
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 86 (6) , 610-612
- https://doi.org/10.1161/01.res.86.6.610
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Phospholipase A2 Modification of Low Density Lipoproteins Forms Small High Density Particles with Increased Affinity for Proteoglycans and GlycosaminoglycansJournal of Biological Chemistry, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Secretory Phospholipase A2 and Lipoprotein Lipase Enhance 15-Lipoxygenase-Induced Enzymic and Nonenzymic Lipid Peroxidation in Low-Density Lipoproteins†Biochemistry, 1998
- Secretory Sphingomyelinase, a Product of the Acid Sphingomyelinase Gene, Can Hydrolyze Atherogenic Lipoproteins at Neutral pHJournal of Biological Chemistry, 1998
- Minimal oxidation and storage of low density lipoproteins result in an increased susceptibility to phospholipid hydrolysis by phospholipase A2Atherosclerosis, 1997
- The Proteoglycan Decorin Links Low Density Lipoproteins with Collagen Type IJournal of Biological Chemistry, 1997
- Regulatory Functions of Phospholipase A2Critical Reviews in Immunology, 1997
- Secretory group II phospholipase A2 in human atherosclerotic plaquesAtherosclerosis, 1995
- Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cellsCell, 1995
- Negative regulation of transforming growth factor-β by the proteoglycan decorinNature, 1990